Literature DB >> 27079633

Dynamics of plasma levels of specific IgE in chlorhexidine allergic patients with and without accidental re-exposure.

M S Opstrup1,2, L K Poulsen1, H J Malling1, B M Jensen1, L H Garvey1.   

Abstract

BACKGROUND: Chlorhexidine is an effective disinfectant, which may cause severe allergic reactions. Plasma level of specific IgE to chlorhexidine (ImmunoCAP(®) ) has high estimated sensitivity and specificity when measured within 6 months of allergic reaction, but knowledge of the dynamics over longer time periods is lacking and it is unknown whether levels fall below <0.35 kUA/L in patients with previously elevated levels. It is also unclear whether re-exposure influences levels of specific IgE.
OBJECTIVE: To investigate the dynamics of specific IgE in chlorhexidine allergic patients with and without re-exposure.
METHODS: All patients diagnosed with chlorhexidine allergy in the Danish Anaesthesia Allergy Centre January 1999 to March 2015 were invited to participate. The study included blood samples from the time of reaction and time of investigation and blood samples drawn prospectively over several years.
RESULTS: Overall, 23 patients were included. Specific IgE within hours of reaction was available in eight patients and was >0.35 kUA/L in six of these. During allergy investigations, usually 2-4 months later, specific IgE was >0.35 kUA/L in 22 of 23 patients. In the following months/years specific IgE declined <0.35 kUA/L in 17 of 23 patients (most rapidly within 4 months). Nine re-exposures in the healthcare setting were reported by seven patients (35%). Most re-exposures caused symptoms and were followed by an increase in specific IgE. Two patients with specific IgE <0.35 kUA/L reacted upon re-exposure. CONCLUSIONS & CLINICAL RELEVANCE: Time from reaction should be considered when interpreting specific IgE results. Specific IgE is >0.35 kUA/L in most patients at time of reaction but should be repeated after a few weeks/months if negative. The optimal sampling time seems to be >1 month and <4 months. A value <0.35 kUA/L neither excludes allergy nor implies loss of reactivity in previously sensitized patients. Re-exposures are common, often iatrogenic, and can cause a rebound in specific IgE.
© 2016 John Wiley & Sons Ltd.

Entities:  

Keywords:  Chlorhexidine; chlorhexidine allergy; specific IgE

Mesh:

Substances:

Year:  2016        PMID: 27079633     DOI: 10.1111/cea.12743

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  13 in total

Review 1.  Antibiotic Allergy in Pediatrics.

Authors:  Allison Eaddy Norton; Katherine Konvinse; Elizabeth J Phillips; Ana Dioun Broyles
Journal:  Pediatrics       Date:  2018-05       Impact factor: 7.124

2.  Chlorhexidine allergy in four specialist allergy centres in the United Kingdom, 2009-13: clinical features and diagnostic tests.

Authors:  W Egner; M Helbert; R Sargur; K Swallow; N Harper; T Garcez; S Savic; L Savic; E Eren
Journal:  Clin Exp Immunol       Date:  2017-03-13       Impact factor: 4.330

Review 3.  Hidden Causes of Anaphylaxis.

Authors:  Vivian C Nanagas; James L Baldwin; Keerthi R Karamched
Journal:  Curr Allergy Asthma Rep       Date:  2017-07       Impact factor: 4.806

Review 4.  The challenge of de-labeling penicillin allergy.

Authors:  Cosby A Stone; Jason Trubiano; David T Coleman; Christine R F Rukasin; Elizabeth J Phillips
Journal:  Allergy       Date:  2019-05-26       Impact factor: 13.146

Review 5.  Beyond IgE-When Do IgE-Crosslinking and Effector Cell Activation Lead to Clinical Anaphylaxis?

Authors:  Lars K Poulsen; Bettina M Jensen; Vanesa Esteban; Lene Heise Garvey
Journal:  Front Immunol       Date:  2017-08-10       Impact factor: 7.561

Review 6.  In Vitro Diagnosis of Immediate Drug Hypersensitivity Anno 2017: Potentials and Limitations.

Authors:  I I Decuyper; E A Mangodt; A L Van Gasse; K Claesen; A Uyttebroek; M Faber; V Sabato; C H Bridts; C Mertens; M M Hagendorens; L S De Clerck; Didier G Ebo
Journal:  Drugs R D       Date:  2017-06

7.  Three cases of anaphylaxis following injection of a depot corticosteroid with evidence of IgE sensitization to macrogols rather than the active steroid.

Authors:  Nicolaj Brandt; Lene H Garvey; Ulla Bindslev-Jensen; Henrik Fomsgaard Kjaer; Carsten Bindslev-Jensen; Charlotte G Mortz
Journal:  Clin Transl Allergy       Date:  2017-01-10       Impact factor: 5.871

8.  Allergy to polyethylene glycol and polysorbates in a patient cohort: Diagnostic work-up and decision points for vaccination during the COVID-19 pandemic.

Authors:  Charlotte G Mortz; Henrik F Kjaer; Trine H Rasmussen; Helene M Rasmussen; Lene Heise Garvey; Carsten Bindslev-Jensen
Journal:  Clin Transl Allergy       Date:  2022-01-08       Impact factor: 5.871

Review 9.  Perioperative Anaphylaxis: Evaluation and Management.

Authors:  Deepti Vellaichamy Manian; Gerald W Volcheck
Journal:  Clin Rev Allergy Immunol       Date:  2021-07-10       Impact factor: 8.667

Review 10.  Chlorhexidine Allergy: Current Challenges and Future Prospects.

Authors:  Chirawat Chiewchalermsri; Mongkhon Sompornrattanaphan; Chamard Wongsa; Torpong Thongngarm
Journal:  J Asthma Allergy       Date:  2020-03-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.